0,957  0,000  Alpha-N-acetylglucosaminidase inhibitor
0,931  0,000  Mannosidase inhibitor
0,927  0,001  Carcinogenic, group 2A
0,910  0,002  Carcinogenic, group 1
0,857  0,006  Teratogen
0,853  0,005  Embryotoxic
0,835  0,002  Aldose reductase substrate
0,834  0,005  Respiratory analeptic
0,830  0,003  Angiogenesis stimulant
0,828  0,001  Amylase inhibitor
0,825  0,005  Antidiabetic
0,825  0,005  Cyclophilin D inhibitor
0,821  0,004  Immunomodulator
0,815  0,005  Cytostatic
0,785  0,018  Antiinflammatory
0,767  0,005  Analeptic
0,763  0,007  Chemoprotective
0,771  0,015  Caspase 9 stimulant
0,750  0,004  DNA synthesis inhibitor
0,745  0,001  Alpha-mannosidase inhibitor
0,751  0,008  Radioprotector
0,744  0,007  Mutagenic
0,738  0,005  Cardioprotectant
0,734  0,005  5 Hydroxytryptamine release stimulant
0,727  0,003  Interleukin agonist
0,710  0,008  Antibacterial
0,711  0,012  Antileukemic
0,698  0,006  NOS3 expression inhibitor
0,699  0,008  Cholesterol antagonist
0,660  0,006  DNA damaging
0,652  0,004  Osteoarthritis treatment
0,659  0,011  Immunostimulant
0,648  0,002  Antispirochetal
0,618  0,002  NADH dehydrogenase inhibitor
0,626  0,014  Antithrombotic
0,612  0,010  Antioxidant
0,605  0,011  Hepatic disorders treatment
0,604  0,015  Sensitization
0,582  0,002  Phosphofructokinase-1 inhibitor
0,600  0,021  Antineoplastic (solid tumors)
0,593  0,018  Carcinogenic
0,582  0,012  Apoptosis antagonist
0,569  0,005  Hepatoprotectant
0,567  0,005  Septic shock treatment
0,563  0,004  Muscular dystrophy treatment
0,567  0,010  Hypoglycemic
0,588  0,033  Transcription factor NF kappa B inhibitor
0,563  0,011  Free radical scavenger
0,563  0,014  UGT1A9 substrate
0,554  0,008  RNA-directed DNA polymerase inhibitor
0,549  0,003  Expectorant
0,595  0,050  Apoptosis agonist
0,558  0,019  Immunosuppressant
0,538  0,002  UDP-glucose 4-epimerase inhibitor
0,537  0,005  Interleukin 2 agonist
0,544  0,015  Antifungal
0,529  0,003  Hexokinase inhibitor
0,504  0,002  Antiviral (Influenza B)
0,506  0,010  UGT2B4 substrate
0,509  0,019  Caspase 3 stimulant
0,526  0,040  TNF expression inhibitor
0,506  0,024  Cytotoxic
0,507  0,025  Antihypercholesterolemic
0,482  0,003  Antineoplastic, alkylator
0,483  0,005  Antiviral (Influenza)
0,509  0,030  Antipruritic, allergic
0,485  0,006  DNA methylase inhibitor
0,479  0,003  Mucolytic
0,480  0,005  Alkylator
0,487  0,013  Vascular (periferal) disease treatment
0,471  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,479  0,016  ICAM1 expression inhibitor
0,475  0,013  Antineoplastic (osteosarcoma)
0,465  0,003  Triose-phosphate isomerase inhibitor
0,461  0,002  Mannose-6-phosphate isomerase inhibitor
0,457  0,004  Peptidyltransferase inhibitor
0,466  0,017  Antineoplastic (lymphoma)
0,458  0,014  Antihypoxic
0,461  0,018  Antiparasitic
0,462  0,023  Antineoplastic (non-Hodgkin's lymphoma)
0,473  0,034  Stroke treatment
0,446  0,008  Phospholipase C inhibitor
0,493  0,058  Antiarthritic
0,445  0,011  Antiviral (Herpes)
0,439  0,006  Antipruritic, non-allergic
0,444  0,012  Antineoplastic (sarcoma)
0,449  0,016  Antihypertriglyceridemic
0,453  0,022  Antidiabetic (type 2)
0,444  0,013  UGT1A1 substrate
0,442  0,012  Anesthetic general
0,426  0,005  Antifungal enhancer
0,420  0,005  Antineoplastic antibiotic
0,418  0,005  Cell wall synthesis inhibitor
0,416  0,008  DNA methyltransferase I inhibitor
0,423  0,015  Wound healing agent
0,431  0,025  Proliferative diseases treatment
0,423  0,018  UDP-glucuronosyltransferase substrate
0,406  0,003  Selectin antagonist
0,418  0,018  Myocardial infarction treatment
0,401  0,008  NOS3 expression enhancer
0,398  0,010  Antineoplastic antimetabolite
0,385  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,379  0,003  Transcription factor NF kappa B stimulant
0,381  0,006  Cystic fibrosis treatment
0,386  0,013  Thrombolytic
0,378  0,011  Lipid peroxidase inhibitor
0,394  0,029  Chemopreventive
0,369  0,005  Antihemorrhagic
0,397  0,036  Vasodilator, coronary
0,363  0,002  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,396  0,041  Antineoplastic (brain cancer)
0,371  0,015  Platelet adhesion inhibitor
0,360  0,011  Protein kinase stimulant
0,401  0,055  Vasodilator, peripheral
0,355  0,010  Antiviral (Influenza A)
0,359  0,017  Antihypotensive
0,351  0,009  Neurotrophic factor enhancer
0,343  0,014  Topoisomerase II inhibitor
0,363  0,035  Tumour necrosis factor alpha release inhibitor
0,359  0,030  Nitric oxide antagonist
0,330  0,002  Caspase 2 inhibitor
0,366  0,039  NOS2 expression inhibitor
0,342  0,024  Antihelmintic
0,358  0,049  Antineoplastic (pancreatic cancer)
0,322  0,014  Antihelmintic (Nematodes)
0,310  0,004  DNA repair enzyme inhibitor
0,315  0,012  Acute respiratory distress syndrome (ARDS) treatment
0,309  0,007  Antibiotic
0,344  0,041  Radiosensitizer
0,338  0,037  Antineoplastic (liver cancer)
0,354  0,054  Antimycobacterial
0,338  0,044  Antipyretic
0,314  0,024  Antimutagenic
0,308  0,023  VCAM1 expression inhibitor
0,295  0,011  Topoisomerase I inhibitor
0,329  0,046  Antiprotozoal (Leishmania)
0,352  0,070  Angiogenesis inhibitor
0,319  0,042  Vasodilator
0,290  0,015  Adenylate cyclase inhibitor
0,303  0,028  Eye irritation, high
0,286  0,018  Genotoxic
0,271  0,003  Antiviral (Dengue virus)
0,332  0,065  AR expression inhibitor
0,275  0,010  Antiviral (Poxvirus)
0,273  0,008  Adenylate kinase inhibitor
0,285  0,022  Interferon gamma antagonist
0,279  0,017  Nitric-oxide synthase stimulant
0,268  0,006  Antiviral (Ebola)
0,265  0,005  Hearing loss treatment
0,265  0,005  Antirickettsial
0,319  0,059  Antiosteoporotic
0,279  0,025  Antiviral (Hepatitis)
0,265  0,013  Neuropathy treatment
0,261  0,008  Antifungal (Cryptococcus)
0,271  0,019  Hemostatic
0,255  0,004  Adenylate cyclase stimulant
0,264  0,013  Uterine stimulant
0,298  0,049  Acute neurologic disorders treatment
0,279  0,032  UGT2B7 substrate
0,258  0,011  Excitatory amino acid transporter EAAC1 inhibitor
0,248  0,005  Carbamoyl phosphate synthetase inhibitor
0,331  0,089  CYP2C9 substrate
0,285  0,048  UGT1A6 substrate
0,316  0,079  Bone diseases treatment
0,238  0,002  Antibiotic Glycopeptide-like
0,330  0,095  GST A substrate
0,237  0,004  Phosphorylase inhibitor
0,233  0,004  Toll-Like receptor 4 antagonist
0,303  0,075  Antineoplastic (small cell lung cancer)
0,228  0,001  Glucose-6-phosphate isomerase inhibitor
0,244  0,018  DNA polymerase I inhibitor
0,233  0,008  Antimetabolite
0,229  0,014  Toll-Like receptor 2 antagonist
0,241  0,028  Skin whitener
0,291  0,080  Antiischemic
0,240  0,029  Carcinogenic, group 3
0,260  0,050  Antiviral (HIV)
0,239  0,030  Melanin inhibitor
0,233  0,027  Interleukin 6 antagonist
0,225  0,022  Toll-Like receptor antagonist
0,206  0,003  Ca2+-transporting ATPase inhibitor
0,230  0,028  Antiviral (Hepatitis C)
0,333  0,131  5 Hydroxytryptamine release inhibitor
0,206  0,005  Neuraminidase (influenza) inhibitor
0,223  0,023  UGT2B10 substrate
0,209  0,010  AMP-activated protein kinase stimulant
0,289  0,091  Antineoplastic (endocrine cancer)
0,221  0,023  Antiviral (Hepatitis B)
0,207  0,009  Chronic obstructive bronchitis treatment
0,200  0,003  Gaucher disease treatment
0,223  0,027  Antidiarrheal
0,196  0,001  Antibiotic Aminoglycoside-like
0,212  0,019  Carcinogenic, group 2B
0,215  0,027  Antiprotozoal (Coccidial)
0,217  0,029  Antidiabetic (type 1)
0,192  0,005  Glutamate release inhibitor
0,203  0,018  Cyclooxygenase 3 inhibitor
0,210  0,025  Psychosexual dysfunction treatment
0,263  0,082  GST M1-1 substrate
0,198  0,019  Antischistosomal
0,185  0,007  Interferon agonist
0,200  0,022  CF transmembrane conductance regulator agonist
0,205  0,033  ATPase inhibitor
0,246  0,076  Antineoplastic (glioma)
0,179  0,010  Neutropenia treatment
0,181  0,012  Glutamate dehydrogenase inhibitor
0,171  0,004  Glucosylceramidase inhibitor
0,229  0,062  Antiviral (West Nile virus)
0,262  0,097  Antipsoriatic
0,200  0,036  Bone formation stimulant
0,187  0,023  GABA C receptor agonist
0,172  0,009  Argininosuccinate synthase inhibitor
0,166  0,005  Neuraminidase inhibitor
0,287  0,128  Antineoplastic (myeloid leukemia)
0,200  0,042  UGT2B15 substrate
0,307  0,156  Alpha-glucosidase inhibitor
0,183  0,032  Aldehyde dehydrogenase inhibitor
0,170  0,020  Aldehyde dehydrogenase substrate
0,157  0,007  GABA aminotransferase inhibitor
0,167  0,018  Sphingomyelinase inhibitor
0,153  0,004  Antimycoplasmal
0,184  0,038  Skin irritative effect
0,266  0,120  CYP3A4 substrate
0,152  0,007  Glycine receptor antagonist
0,160  0,016  Aminoacyl-tRNA synthetase inhibitor
0,149  0,006  Na+ K+ transporting ATPase inhibitor
0,169  0,026  Anticataract
0,141  0,001  Protein 30S ribosomal subunit inhibitor
0,146  0,007  Protein 50S ribosomal subunit inhibitor
0,168  0,030  Growth stimulant
0,163  0,025  Protein kinase C gamma inhibitor
0,164  0,026  Alcohol dehydrogenase substrate
0,193  0,057  Antineoplastic (gastric cancer)
0,143  0,008  Glycine receptor agonist
0,220  0,086  Antineoplastic (lymphocytic leukemia)
0,139  0,005  Interferon inducer
0,179  0,051  Antidote
0,154  0,027  Carbonic anhydrase III inhibitor
0,149  0,022  Antifungal (Pneumocystis)
0,228  0,103  Huntington's disease treatment
0,143  0,019  Thioredoxin inhibitor
0,197  0,073  Abortion inducer
0,133  0,012  Biliverdin reductase inhibitor
0,161  0,041  Retinoprotector
0,130  0,011  Acyl-CoA dehydrogenase inhibitor
0,150  0,031  Photosensitizer
0,161  0,043  Monophenol monooxygenase inhibitor
0,126  0,009  Antiviral (Herpesvirus 3, Human)
0,157  0,040  DNA intercalator
0,115  0,004  Cytokine production stimulant
0,129  0,018  Phosphodiesterase 6D inhibitor
0,135  0,025  GST T1-1 substrate
0,134  0,025  Carbonic anhydrase VI inhibitor
0,130  0,022  Antiviral (Trachoma)
0,125  0,017  ATPase (Vacuolar H+) inhibitor
0,201  0,093  Cyclic AMP phosphodiesterase inhibitor
0,109  0,003  Sodium/glucose cotransporter 2 inhibitor
0,110  0,005  Glucose-6-phosphate translocase inhibitor
0,111  0,009  Antiviral (Parainfluenza)
0,112  0,009  Antitreponemal
0,107  0,005  Adenosine deaminase inhibitor
0,128  0,028  UGT2B11 substrate
0,108  0,009  Carbonic anhydrase XIV inhibitor
0,131  0,033  Antiprotozoal (Toxoplasma)
0,133  0,036  Sulfotransferase substrate
0,275  0,180  Calcium channel L-type activator
0,099  0,005  Adenine nucleotide translocase inhibitor
0,138  0,044  Microtubule formation inhibitor
0,151  0,058  Neurotrophic factor
0,095  0,003  Sodium/glucose cotransporter inhibitor
0,146  0,055  Heat shock protein 70 antagonist
0,158  0,067  Acaricide
0,119  0,030  Topoisomerase II alpha inhibitor
0,095  0,007  Phosphoglycerate kinase inhibitor
0,103  0,015  Ornithine carbamoyltransferase inhibitor
0,134  0,047  Glutathione S-transferase substrate
0,090  0,003  Uridine phosphorylase inhibitor
0,088  0,002  Toll-Like receptor 4 agonist
0,205  0,119  Antineoplastic (ovarian cancer)
0,106  0,024  Adenosine A3 receptor antagonist
0,237  0,154  Ulceration
0,100  0,017  Protein kinase C eta inhibitor
0,183  0,101  Antiulcerative
0,112  0,033  Carbonic anhydrase XIII inhibitor
0,084  0,005  Heparanase inhibitor
0,165  0,088  Diabetic nephropathy treatment
0,079  0,003  Ceramide glucosyltransferase inhibitor
0,094  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,082  0,006  Equilibrative nucleoside transport protein inhibitor
0,084  0,008  Thymidine kinase inhibitor
0,079  0,005  Neuraminidase (Influenza A) inhibitor
0,078  0,003  Guanylate cyclase inhibitor
0,080  0,006  Arginase inhibitor
0,106  0,032  Antileprosy
0,098  0,026  Narcotic antagonist
0,091  0,019  Protein kinase C beta inhibitor
0,134  0,063  Antihyperlipoproteinemic
0,090  0,020  Purinergic P2X1 antagonist
0,132  0,063  Vanilloid 1 agonist
0,148  0,083  Anticoagulant
0,118  0,054  Choleretic
0,070  0,006  Hypoxanthine phosphoribosyltransferase inhibitor
0,071  0,008  Fumarate hydratase inhibitor
0,131  0,070  Interleukin 4 antagonist
0,136  0,075  Antineoplastic (squamous cell carcinoma)
0,066  0,005  Nucleoside transporters inhibitor
0,077  0,017  Sphingosine kinase 2 inhibitor
0,102  0,042  Ornithine decarboxylase inhibitor
0,111  0,051  Dementia treatment
0,206  0,146  CYP1A2 substrate
0,138  0,079  SULT1A3 substrate
0,103  0,044  Actinic keratosis treatment
0,230  0,171  Histamine release inhibitor
0,123  0,065  Antiprotozoal (Amoeba)
0,101  0,043  Arylamine N-Acetyltransferase substrate
0,107  0,049  Vascular dementia treatment
0,148  0,090  Arachidonic acid antagonist
0,121  0,065  Cell adhesion inhibitor
0,060  0,004  Caspase 6 inhibitor
0,075  0,019  Sphingosine kinase inhibitor
0,078  0,024  Nitric oxide donor
0,112  0,061  GABA C receptor antagonist
0,170  0,120  Antialcoholic
0,054  0,004  Sodium/glucose cotransporter 1 inhibitor
0,200  0,151  5 Hydroxytryptamine uptake stimulant
0,056  0,007  Cholesterol absorption inhibitor
0,066  0,019  Toll-Like receptor 2 agonist
0,124  0,077  Antiacne
0,052  0,006  Adenosine kinase inhibitor
0,051  0,005  Adenosine A1 receptor agonist
0,047  0,001  Telomerase stimulant
0,045  0,002  Antibiotic Anthracycline-like
0,081  0,038  Prokinetic
0,180  0,137  Spasmolytic
0,046  0,004  GRP78 expression inhibitor
0,045  0,003  Vanilloid 2 agonist
0,074  0,033  Glutamate (mGluR6) antagonist
0,100  0,059  Xanthine oxidase inhibitor
0,093  0,054  Antidote, mercury
0,103  0,065  Beta glucuronidase inhibitor
0,051  0,015  Sphingosine kinase 1 inhibitor
0,039  0,003  Isoleucine-tRNA ligase inhibitor
0,103  0,067  UGT2B1 substrate
0,039  0,004  Adenosine A2 receptor agonist
0,041  0,006  Purinergic P2Y15 antagonist
0,040  0,006  Thymidine phosphorylase inhibitor
0,079  0,045  Histone deacetylase SIRT1 stimulant
0,079  0,045  Histone deacetylase stimulant
0,037  0,004  Adenosine A2a receptor agonist
0,068  0,035  Antidote, heavy metal
0,063  0,030  Lipocortins synthesis agonist
0,093  0,060  Falcipain inhibitor
0,082  0,049  Somatostatin 1 agonist
0,067  0,035  Adenosine A1 receptor antagonist
0,036  0,005  1,3-Beta-glucan synthase inhibitor
0,111  0,080  Constipation treatment
0,090  0,059  Falcipain 2 inhibitor
0,071  0,041  SULT2A1 substrate
0,056  0,027  Anesthetic inhalation
0,058  0,029  Factor IXa inhibitor
0,117  0,088  Antihelmintic (Trematoda)
0,078  0,051  MAP kinase kinase 7 inhibitor
0,090  0,062  Restless leg syndrome treatment
0,082  0,057  Thioredoxin reductase inhibitor
0,104  0,079  Antitussive
0,095  0,070  Anabolic
0,129  0,104  UGT2B9 substrate
0,038  0,013  Glutamate (mGluR3) agonist
0,033  0,008  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,145  0,121  Cardiodepressant
0,048  0,024  AICAR transformylase inhibitor
0,094  0,071  GABA C receptor rho-1 antagonist
0,107  0,087  Transcription factor STAT6 inhibitor
0,091  0,071  Interleukin 1 beta converting enzyme inhibitor
0,088  0,069  Protein kinase C zeta inhibitor
0,082  0,063  Antineoplastic alkaloid
0,035  0,017  Protein kinase C beta I inhibitor
0,025  0,006  Ileal bile acid transport inhibitor
0,097  0,080  Cystathionine beta-synthase inhibitor
0,056  0,038  Ribonucleotide reductase inhibitor
0,088  0,071  Antiviral (Rhinovirus)
0,019  0,002  Purinergic P2Y2 agonist
0,022  0,005  Purinergic P2Y1 agonist
0,023  0,007  Adenosine A3 receptor agonist
0,155  0,138  Antineoplastic (cervical cancer)
0,032  0,016  DNA topoisomerase IV inhibitor
0,032  0,016  Purinergic P2X agonist
0,086  0,070  Alcohol dehydrogenase inhibitor
0,050  0,034  Squalene epoxidase inhibitor
0,049  0,034  Topoisomerase II beta inhibitor
0,024  0,011  Inosine monophosphate dehydrogenase 1 inhibitor
0,110  0,097  Antibacterial (Helicobacter pylori)
0,058  0,046  Adenosine A2a receptor antagonist
0,020  0,008  Methylmalonyl-CoA mutase inhibitor
0,019  0,007  Purinergic P2 agonist
0,019  0,007  Purinergic receptor agonist
0,018  0,007  Antibiotic Macrolide-like
0,022  0,012  Neuraminidase (Influenza B) inhibitor
0,064  0,055  Antihemophilic
0,148  0,139  Hypolipemic
0,120  0,111  Insulin secretagoues
0,165  0,157  Antiprotozoal (Trypanosoma)
0,016  0,009  S-adenosyl-L-homocysteine hydrolase inhibitor
0,016  0,008  Adenosine A2b receptor agonist
0,018  0,010  O6-alkylguanine-DNA alkyltransferase inhibitor
0,014  0,007  Purinergic P2Y agonist
0,049  0,042  Ribonucleoside-diphosphate reductase inhibitor
0,173  0,167  CYP2C19 substrate
0,201  0,197  FMO1 substrate
0,064  0,060  Catalase inhibitor
0,050  0,047  Peristaltic stimulant
0,035  0,032  Glutamate (mGluR8) agonist
0,003  0,002  Purinergic P2Y6 agonist
0,011  0,009  Purine nucleoside phosphorylase inhibitor
0,107  0,106  Gastritis treatment
0,011  0,010  Glutamate (mGluR6) agonist

